OSIRIS THERAPEUTICS INC NEW's ticker is OSIR and the CUSIP is 68827R108. A total of 70 filers reported holding OSIRIS THERAPEUTICS INC NEW in Q2 2016. The put-call ratio across all filers is 1.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $118,000 | -17.5% | 23,690 | -15.6% | 0.00% | 0.0% |
| Q2 2016 | $143,000 | -9.5% | 28,080 | +1.6% | 0.00% | 0.0% |
| Q1 2016 | $158,000 | -50.0% | 27,646 | -9.3% | 0.00% | -50.0% |
| Q4 2015 | $316,000 | -39.1% | 30,484 | +8.5% | 0.00% | -42.9% |
| Q3 2015 | $519,000 | -10.8% | 28,086 | -6.0% | 0.01% | -12.5% |
| Q2 2015 | $582,000 | +5.6% | 29,885 | -4.6% | 0.01% | +33.3% |
| Q1 2015 | $551,000 | +28.7% | 31,318 | +16.9% | 0.01% | +20.0% |
| Q4 2014 | $428,000 | +35.0% | 26,793 | +6.3% | 0.01% | +25.0% |
| Q3 2014 | $317,000 | -32.4% | 25,206 | -16.0% | 0.00% | -33.3% |
| Q2 2014 | $469,000 | -16.4% | 30,008 | -29.7% | 0.01% | -14.3% |
| Q1 2014 | $561,000 | +116.6% | 42,694 | +165.6% | 0.01% | +75.0% |
| Q4 2013 | $259,000 | -29.4% | 16,076 | -27.1% | 0.00% | -55.6% |
| Q3 2013 | $367,000 | +114.6% | 22,061 | +29.8% | 0.01% | +200.0% |
| Q2 2013 | $171,000 | – | 16,991 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 1,579,561 | $19,887,000 | 2.73% |
| PRINCETON CAPITAL MANAGEMENT INC | 35,825 | $451,000 | 0.29% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 388,039 | $4,885,000 | 0.18% |
| ELLINGTON MANAGEMENT GROUP LLC | 15,700 | $198,000 | 0.14% |
| Baker Brothers Advisors | 510,606 | $6,429,000 | 0.08% |
| Rodgers Brothers Inc. | 10,400 | $131,000 | 0.07% |
| Nine Chapters Capital Management LLC | 31,800 | $400,000 | 0.04% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 71,037 | $895,000 | 0.02% |
| KILLEN GROUP INC | 34,600 | $436,000 | 0.02% |
| Freedom Investment Management, Inc. | 10,591 | $133,000 | 0.02% |